SCHEMBL8065343

SCHEMBL8065343

COC(=O)[C@H](CCCC(C)(C)N)NC(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.56
SIRT1 Q96EB6 1/20 0.56
SIRT3 Q9NTG7 1/20 0.56
KYNU Q16719 1/20 0.55
ALDH1A1 P00352 2/20 0.53
ALOX15 P16050 1/20 0.53
CTSL P07711 4/20 0.53
CTSS P25774 3/20 0.53
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CTSB P07858 2/20 0.51
MBOAT4 Q96T53 1/20 0.50
CTSK P43235 3/20 0.49
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3621173 0.91 SIRT2 (0.55) SIRT2SIRT1CTSLCTSSCTSB
SCHEMBL8386880 0.88 SIRT2 (0.67) SIRT2SIRT1SIRT3KYNUALDH1A1
SCHEMBL15665249 0.88 SIRT2 (0.56) SIRT2SIRT1SIRT3KYNUALDH1A1
SCHEMBL15664902 0.86 SIRT2 (0.60) SIRT2SIRT1SIRT3KYNUALDH1A1
SCHEMBL15664900 0.86 SIRT2 (0.60) SIRT2SIRT1SIRT3KYNUALDH1A1
SCHEMBL8447232 0.86 SIRT2 (0.59) SIRT2SIRT1SIRT3KYNUALDH1A1
SCHEMBL8447229 0.86 SIRT2 (0.59) SIRT2SIRT1SIRT3KYNUALDH1A1
Hydrochloric Acid SCHEMBL6236103 0.85 SIRT2 (0.58) SIRT2SIRT1SIRT3KYNUALDH1A1
SCHEMBL1840311 0.85 SIRT2 (0.61) SIRT2SIRT1SIRT3KYNUALDH1A1
Hydrochloric Acid SCHEMBL6236109 0.85 SIRT2 (0.58) SIRT2SIRT1SIRT3KYNUALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100093811-A1 HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-04-15 US disclosed
US-20100093811-A1 HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-04-15 US disclosed
WO-2009042093-A1 HIV PROTEASE INHIBITORS MERCK & CO., INC. (US) 2009-04-02 WO disclosed
WO-2009042094-A2 HIV PROTEASE INHIBITORS MERCK & CO., INC. (US) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093811-A1 HIV PROTEASE INHIBITORS PRSS1, FURIN, SERPINB1 SIRT2 1673/4885SIRT1 474/4885SIRT3 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.